Skip Navigation
Search site

We are building you a better website. You might be interested to see the new look here, and let us know what you think.

National Oesophago-Gastric Cancer Audit

The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer and oesophageal High-grade Glandular Dysplasia (HGD). The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative.


The 2016 Annual Report was published on 8 September 2016 and is available here.

The Local Action Plan (LAP) and presentation slides for local use (comparing national data with local data) are also available on the 2016 Annual Report page.

The audit is currently collecting data for the 2017 Annual Report, patients diagnosed between 1 April 2015 and 31 March 2016. The second submission deadline is Friday 3 February.  After this date, the audit data is linked to ONS and HES data and no further patients can be added for the 2017 Annual Report and the Clinical Outcomes Publication, only treatment data.

What does it report?

  • characteristics of patients, their cancers and treatment selection
  • patterns of care received by curative and palliative patients
  • short-term outcomes of both curative and palliative treatments
  • survival rates of patients
  • differences in survival rates by patient characteristics, cancer type and the treatments received
  • patients with oesophageal High-Grade Glandular Dysplasia (HGD).


Survival depends on early diagnosis. The management of patients with this type of cancer is complex. The audit hopes to improve the process of care and the outcomes of treatment for all cancer patients, both curative and palliative by

  • producing up-to-date information on the quality of care for OG cancer patients
  • providing downloadable data for OG cancer units on their practice and outcomes
  • satisfying General Medical Council (GMC) requirements for performance assessment and revalidation
  • directly supporting the "cancer measures" element of the peer review process.

Who manages the audit?

The audit is managed as a partnership between a team of clinicians and audit experts from:

  • The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS)
  • British Society of Gastroenterologists (BSG)
  • Royal College of Radiologists (RCR)
  • The Clinical Effectiveness Unit at the Royal College of Surgeons of England
  • NHS Digital

The National Oesophago-Gastric Cancer Audit is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP).

What is included in the audit?

  1. a prospective study examining the care pathway and outcome for individual patients
  2. an organisational survey of all OG cancer units in England and Wales
  3. detailed analysis of existing data sources to describe recent patterns of OG cancer treatment.

How to participate

Trusts that provide care to patients with OG cancer and HGD should participate in this audit.  All data for the audit is submitted via the NHS Digital Clinical Audit Platform (CAP): Data can be submitted directly into CAP or via CSV file upload.  The CSV specification can be found within Excel Dataset Validation Workbook.

Trusts can register to access CAP by completing the User Registration Form found under User Documents to the right of this page.  Once registered, users can access CAP by clicking on this link:

Details of how to download NOGCA CSV files from the Somerset Cancer Registry (SCR) can be found in the 'Understanding the National Oesophago-Gastric Cancer Audit in SCR' user guide.  This and the 'NOGCA/SCR Technical Mapping Document' can be found on the SCR website (only accessible from an N3 Network) at the following address:

Publication of the audit results

The 2016 Annual Report was published on 8 September 2016.

The 2016 Consultant Outcomes Publication was published in August 2016 on the AUGIS website and will be published In November 2016 on NHS Choices and includes patients diagnosed between 1 April 2012 and 31 March 2015.  It can be accessed at the following links:


Use of Audit Tools and Documentation Outside of the Clinical Audit

You hereby agree that in downloading or using the documents or tools on this web page for any use outside of the project for which it was developed, you are entering into a royalty free, non-exclusive, licence agreement with the Healthcare Quality Improvement Partnership under the following Terms and Conditions:
All information, software, products and related graphics contained in the audit tool or data collection form are provided for non-commercial purposes  "as is" without warranty, including but not limited to the implied warranties of satisfactory quality, fitness for a particular purpose, title and non-infringement of third party intellectual property rights. In no event shall HQIP be liable for any direct, indirect, incidental, special or consequential damages for loss of profits, revenue, data or use incurred by you or any third party, whether in action in contract, tort, or otherwise, arising from your access to, or use of, the audit tool or form. HQIP make no representations about the suitability, reliability, or timeliness, and accuracy of the information, software, products and related graphics contained in the audit tool or forms. HQIP reserves the right to make improvements, changes or updates to forms or tools at any time without notice.

Close iCM Form